Home » Topics » Regulatory

Regulatory
RSS

Synvisc under study for osteoarthritis of the hip

Nov. 11, 1999

Important new indication for Remicade approved by FDA

Nov. 11, 1999

Amgen's epoetin alfa approved in children with chronic renal failure

Nov. 8, 1999

Glaxo Wellcome files for approval of new Relenza indications: influenza prophylaxis, pediatric use

Nov. 8, 1999

Nasonex Nasal Spray approved in E.U. for use in young children

Nov. 8, 1999

First approval granted for Melacine melanoma therapeutic vaccine

Nov. 5, 1999

FDA advisory panel recommends approval of PMDD treatment

Nov. 5, 1999

Celecoxib in FAP: results of clinical trial discussed at ACG

Nov. 2, 1999

Zyprexa now heading for final approval for new indication

Oct. 29, 1999

CPMP gives favorable opinion on Taxotere for advanced non-small cell lung cancer

Oct. 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.